Absence of detectable HIV-1 provirus DNA after early highly active antiretroviral therapy in children infected by vertical transmission
Muñoz-Almagro, C.; Fortuny, C.; Juncosa, T.; Garcia-Fructuoso, M.T.; Gonzalez-Cuevas, A.; Latorre, C.
Journal of Acquired Immune Deficiency Syndromes 31(4): 450-452
2002
ISSN/ISBN: 1525-4135 PMID: 12447018 DOI: 10.1097/00126334-200212010-00013Document Number: 625494
Document emailed within 0-6 h
Related Documents
Brambilla, P.; Bricalli, D.; Sala, N.; Renzetti, F.; Manzoni, P.; Vanzulli, A.; Chiumello, G.; di Natale, B.; Viganò, A. 2001: Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy Aids 15(18): 2415-2422Homsy, J.; Moore, D.; Barasa, A.; Were, W.; Likicho, C.; Waiswa, B.; Downing, R.; Malamba, S.; Tappero, J.; Mermin, J. 2010: Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda Journal of Acquired Immune Deficiency Syndromes 53(1): 28-35
Lapphra, K.; Vanprapar, N.; Phongsamart, W.; Chearskul, P.; Chokephaibulkit, K. 2005: Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 88(7): 956-966
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Piloya, T.; Bakeera-Kitaka, S.; Kekitiinwa, A.; Kamya, M.R. 2012: Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study Journal of the International Aids Society 15(2): 17427
Sophan, S.; Meng, C.Y.; Pean, P.; Harwell, J.; Hutton, E.; Trzmielina, S.; Somasundaran, M.; Luzuriaga, K.; Pugatch, D. 2010: Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART) Southeast Asian Journal of Tropical Medicine and Public Health 41(1): 126-137
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Palacios, G.C.; Montalvo, M.S.; Fraire, M.I.; Leon, E.; Alvarez, M.T.; Solorzano, F. 2008: Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy International Journal of Pediatric Otorhinolaryngology 72(11): 1671-1681
Cerqueira, D.F.; Portela, M.B.; Pomarico, L.; de Araújo Soares, R.M.; de Souza, I.P.R.; Castro, G.ór.F. 2010: Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 39(2): 188-194
Musoke, P.M.; Mudiope, P.; Barlow-Mosha, L.N.; Ajuna, P.; Bagenda, D.; Mubiru, M.M.; Tylleskar, T.; Fowler, M.G. 2010: Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study Bmc Pediatrics 10: 56
Lee, B.; Aurpibul, L.; Sirisanthana, V.; Mangklabruks, A.; Sirisanthana, T.; Puthanakit, T. 2009: Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand HIV Medicine 10(2): 72-78
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Farquhar, C.; Wamalwa, D.; Selig, S.; John-Stewart, G.; Mabuka, J.; Majiwa, M.; Sutton, W.; Haigwood, N.; Wariua, G.; Lohman-Payne, B. 2009: Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination Pediatric Infectious Disease Journal 28(4): 295-299
Deng, X.-j.; He, Y.; Yang, L.; Zou, S.-p.; Yang, H.; Zheng, Y.-h. 2011: The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients Zhonghua Nei Ke Za Zhi 50(3): 230-234
Silveira, M.P.T.; Guttier, M.íl.C.; Pinheiro, C.A.T.; Pereira, T.V.S.; Cruzeiro, A.L.S.; Moreira, L.B. 2012: Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy Revista Brasileira de Psiquiatria 34(2): 162-167
Sevastianova, K.; Sutinen, J.; Westerbacka, J.; Ristola, M.; Yki-Järvinen, H. 2005: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy Antiviral Therapy 10(8): 925-935